Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population

Recruiting now · Phase 4

Conditions studied: Symptomatic Aortic Stenosis

In brief

The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.

Key facts

Study ID

NCT02803294

Run by

Second Affiliated Hospital, Zhejiang University, School of Medicine

People needed

2000

Starts

2016-06-01

Expected to finish

2027-07-01

Last updated by the study team

2021-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with symptomatic aortic stenosis/regurgitation
• Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
• The subject agrees to comply with specified follow-up evaluations and to return to the investigational site where the procedure was performed.
• Patients are technical and anatomical eligible for interventions

You may not qualify if…

• A known hypersensitivity or contraindication to any of the following which cannot be adequately pre-medicated: Aspirin Heparin (HIT/HITTS) and bivalirudin Nitinol (titanium or nickel) Ticlopidine and clopidogrel Contrast media
• Subject refuses a blood transfusion.
• Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the subject from appropriate consent.
• Life expectancy is less than one year

Where it is running

• The Second Affiliated Hospital, School of Medicine at Zhejiang University — Hanzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.